Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Over the counter: The potential for easing pharmacy provision of family planning in urban Senegal.

Peterson J, Brunie A, Diop I, Diop S, Stanback J, Chin-Quee DS.

Gates Open Res. 2019 May 15;2:29. doi: 10.12688/gatesopenres.12825.3. eCollection 2018.

2.

To be continued: family planning continuation among the urban poor in Senegal, a prospective, longitudinal descriptive study.

Peterson J, Brunie A, Ndeye S, Diatta E, Stanback J, Chin-Quee D.

Gates Open Res. 2018 Dec 3;2:65. doi: 10.12688/gatesopenres.12880.1.

3.

Family planning provision in pharmacies and drug shops: an urgent prescription.

Chin-Quee DS, Stanback J, Orr T.

Contraception. 2018 Nov;98(5):379-382. doi: 10.1016/j.contraception.2018.08.013. Epub 2018 Aug 28.

PMID:
30170029
4.

Seeking Synchrony Between Family Planning and Immunization: A Week-10 DMPA Start Option for Breastfeeding Mothers.

Stanback J.

Glob Health Sci Pract. 2017 Sep 28;5(3):341-344. doi: 10.9745/GHSP-D-17-00063. Print 2017 Sep 27. No abstract available.

5.

Proposed clinical guidance for excluding pregnancy prior to contraceptive initiation.

Stanback J, Yacobson I, Harber L.

Contraception. 2017 Apr;95(4):326-330. doi: 10.1016/j.contraception.2016.11.003. Epub 2016 Nov 22. No abstract available.

PMID:
27888046
6.

In support of community-based emergency contraception.

Chin-Quee DS, Stanback J, Graham V.

Contraception. 2016 Jul;94(1):1-5. doi: 10.1016/j.contraception.2016.03.002. Epub 2016 Mar 17. No abstract available.

PMID:
26996736
7.

Community-based provision of family planning in the developing world: recent developments.

Malkin MA, Stanback J.

Curr Opin Obstet Gynecol. 2015 Dec;27(6):482-6. doi: 10.1097/GCO.0000000000000214. Review.

PMID:
26390247
8.

WHO Tiered-Effectiveness Counseling Is Rights-Based Family Planning.

Stanback J, Steiner M, Dorflinger L, Solo J, Cates W Jr.

Glob Health Sci Pract. 2015 Aug 12;3(3):352-7. doi: 10.9745/GHSP-D-15-00096. Review. No abstract available.

9.

Getting closer to people: family planning provision by drug shops in Uganda.

Akol A, Chin-Quee D, Wamala-Mucheri P, Namwebya JH, Mercer SJ, Stanback J.

Glob Health Sci Pract. 2014 Nov 13;2(4):472-81. doi: 10.9745/GHSP-D-14-00085.

10.

Sale and provision of injectable contraceptives in drug shops in developing countries: conclusions from a technical consultation.

Stanback J, Lebetkin E, Orr T, Malarcher S; Family Planning Provision in Drug Shops Technical Consultation Participants.

Contraception. 2015 Feb;91(2):93-6. doi: 10.1016/j.contraception.2014.11.007. Epub 2014 Nov 15. No abstract available.

PMID:
25604899
11.

Author response to letter to the editor: response to commentary titled "Global family planning metrics--time for new definitions".

Stanback J, Maggwa B, Cates W Jr.

Contraception. 2015 Apr;91(4):357. doi: 10.1016/j.contraception.2014.12.006. Epub 2014 Dec 19. No abstract available.

PMID:
25530100
12.

Does free pregnancy testing reduce service denial in family planning clinics? A cluster-randomized experiment in Zambia and Ghana.

Stanback J, Vance G, Asare G, Kasonde P, Kafulubiti B, Chen M, Janowitz B.

Glob Health Sci Pract. 2013 Sep 24;1(3):382-8. doi: 10.9745/GHSP-D-13-00011. eCollection 2013 Nov.

13.

"A cup of tea with our CBD agent … ": community provision of injectable contraceptives in Kenya is safe and feasible.

Olawo AA, Bashir I, Solomon M, Stanback J, Ndugga BM, Malonza I.

Glob Health Sci Pract. 2013 Sep 30;1(3):308-15. doi: 10.9745/GHSP-D-13-00040. eCollection 2013 Nov.

14.

Family planning and the post-2015 development agenda.

Petruney T, Wilson LC, Stanback J, Cates W Jr.

Bull World Health Organ. 2014 Aug 1;92(8):548-548A. doi: 10.2471/BLT.14.142893. No abstract available.

15.

Global family planning metrics - time for new definitions?

Cates W Jr, Stanback J, Maggwa B.

Contraception. 2014 Nov;90(5):472-5. doi: 10.1016/j.contraception.2014.06.037. Epub 2014 Jul 1. No abstract available.

PMID:
25085654
16.

Injectable contraceptive sales at licensed chemical seller shops in ghana: access and reported use in rural and periurban communities.

Lebetkin E, Orr T, Dzasi K, Keyes E, Shelus V, Mensah S, Nagai H, Stanback J.

Int Perspect Sex Reprod Health. 2014 Mar;40(1):21-7. doi: 10.1363/4002114.

PMID:
24733058
17.

Comment on "Suspect online sellers and contraceptive access".

Stanback J, Grossman D, Steiner M.

Contraception. 2013 Oct;88(4):582-3. doi: 10.1016/j.contraception.2013.03.007. Epub 2013 Mar 26. No abstract available.

PMID:
23602029
18.

Integrating family planning messages into immunization services: a cluster-randomized trial in Ghana and Zambia.

Vance G, Janowitz B, Chen M, Boyer B, Kasonde P, Asare G, Kafulubiti B, Stanback J.

Health Policy Plan. 2014 May;29(3):359-66. doi: 10.1093/heapol/czt022. Epub 2013 Apr 9.

PMID:
23570834
19.

Community-based distribution of injectable contraceptives: introduction strategies in four sub-Saharan African countries.

Hoke T, Brunie A, Krueger K, Dreisbach C, Akol A, Rabenja NL, Olawo A, Stanback J.

Int Perspect Sex Reprod Health. 2012 Dec;38(4):214-9. doi: 10.1363/3821412. No abstract available.

PMID:
23318171
20.

Task sharing in family planning.

Janowitz B, Stanback J, Boyer B.

Stud Fam Plann. 2012 Mar;43(1):57-62. No abstract available.

PMID:
23185872
21.

Old barriers need not apply: opening doors for new contraceptives in the developing world.

Greene E, Stanback J.

Contraception. 2012 Jan;85(1):11-4. doi: 10.1016/j.contraception.2011.05.004. No abstract available.

PMID:
22067795
22.

Provision of DMPA by community health workers: what the evidence shows.

Malarcher S, Meirik O, Lebetkin E, Shah I, Spieler J, Stanback J.

Contraception. 2011 Jun;83(6):495-503. doi: 10.1016/j.contraception.2010.08.013. Epub 2010 Oct 6. Review.

PMID:
21570545
23.

Injected with controversy: sales and administration of injectable contraceptives in drug shops in Uganda.

Stanback J, Otterness C, Bekiita M, Nakayiza O, Mbonye AK.

Int Perspect Sex Reprod Health. 2011 Mar;37(1):24-9. doi: 10.1363/3702411.

PMID:
21478085
24.

Excluding pregnancy among women initiating antiretroviral therapy: efficacy of a family planning job aid.

Torpey K, Mwenda L, Kabaso M, Malebe T, Makelele P, Mwema F, Phiri H, Mukundu J, Weaver MA, Stanback J.

BMC Public Health. 2010 May 14;10:249. doi: 10.1186/1471-2458-10-249.

25.

Community-based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation.

Stanback J, Spieler J, Shah I, Finger WR; Expanding Access to Injectable Contraceptives Technical Consultation Participants.

Contraception. 2010 Mar;81(3):181-4. doi: 10.1016/j.contraception.2009.10.006. Epub 2009 Dec 2. No abstract available.

PMID:
20159172
26.

Re: Self-administration of injectable contraceptives.

Stanback J, Krueger K.

Contraception. 2008 Dec;78(6):514. doi: 10.1016/j.contraception.2008.07.007. Epub 2008 Sep 6. No abstract available.

PMID:
19014801
27.

Injectable contraception: what should the longest interval be for reinjections?

Steiner MJ, Kwok C, Stanback J, Byamugisha JK, Chipato T, Magwali T, Mmiro F, Rugpao S, Sriplienchan S, Morrison C.

Contraception. 2008 Jun;77(6):410-4. doi: 10.1016/j.contraception.2008.01.017. Epub 2008 Apr 10.

PMID:
18477489
28.

Validation of a job aid to rule out pregnancy among family planning clients in Nicaragua.

Stanback J, Nanda K, Ramirez Y, Rountree W, Cameron SB.

Rev Panam Salud Publica. 2008 Feb;23(2):116-8.

PMID:
18371282
29.

Pelvic inflammatory disease attributable to the IUD: modeling risk in West Africa.

Stanback J, Shelton JD.

Contraception. 2008 Apr;77(4):227-9. doi: 10.1016/j.contraception.2008.01.001. Epub 2008 Mar 4.

PMID:
18342643
30.

Contraceptive injections by community health workers in Uganda: a nonrandomized community trial.

Stanback J, Mbonye AK, Bekiita M.

Bull World Health Organ. 2007 Oct;85(10):768-73.

31.

Timeliness of contraceptive reinjections in South Africa and its relation to unintentional discontinuation.

Baumgartner JN, Morroni C, Mlobeli RD, Otterness C, Myer L, Janowitz B, Stanback J, Buga G.

Int Fam Plan Perspect. 2007 Jun;33(2):66-74.

32.

Reaching providers is not enough to increase IUD use: a factorial experiment of 'academic detailing' in Kenya.

Wesson J, Olawo A, Bukusi V, Solomon M, Pierre-Louis B, Stanback J, Janowitz B.

J Biosoc Sci. 2008 Jan;40(1):69-82. Epub 2007 Apr 20.

PMID:
17445330
33.

Improving adherence to family planning guidelines in Kenya: an experiment.

Stanback J, Griffey S, Lynam P, Ruto C, Cummings S.

Int J Qual Health Care. 2007 Apr;19(2):68-73. Epub 2007 Feb 2.

PMID:
17277011
34.

Does assessment of signs and symptoms add to the predictive value of an algorithm to rule out pregnancy?

Stanback J, Nakintu N, Qureshi Z, Nasution M.

J Fam Plann Reprod Health Care. 2006 Jan;32(1):27-9.

35.

Access to modern contraception.

Welsh MJ, Stanback J, Shelton J.

Best Pract Res Clin Obstet Gynaecol. 2006 Jun;20(3):323-38. Epub 2006 Jan 26.

PMID:
16443395
36.

Ruling out pregnancy among family planning clients: the impact of a checklist in three countries.

Stanback J, Diabate F, Dieng T, de Morales TD, Cummings S, Traoré M.

Stud Fam Plann. 2005 Dec;36(4):311-5.

PMID:
16395948
37.

Advance provision of oral contraceptives to family planning clients in Kenya.

Stanback J, Qureshi ZP, Sekkade-Kigondu C.

East Afr Med J. 2002 May;79(5):257-8.

PMID:
12638810
38.

Provider resistance to advance provision of oral contraceptives in Africa.

Stanback J, Janowitz B.

J Fam Plann Reprod Health Care. 2003 Jan;29(1):35-6.

39.

Hormonal pregnancy test redux.

Stanback J, Raymond E, Janowitz B.

Contraception. 2002 Oct;66(4):295-6. No abstract available.

PMID:
12413628
40.

Methodological quality of WHO medical eligibility criteria for contraceptive use.

Stanback J, Katz K.

Contraception. 2002 Jul;66(1):1-5.

PMID:
12169373
41.

Hormonal pregnancy tests in sub-Saharan Africa.

Stanback J, Raymond E.

Am J Public Health. 2001 Oct;91(10):1614-5. No abstract available.

42.

Checklist for ruling out pregnancy among family-planning clients in primary care.

Stanback J, Qureshi Z, Sekadde-Kigondu C, Gonzalez B, Nutley T.

Lancet. 1999 Aug 14;354(9178):566.

PMID:
10470704
43.

Menstruation requirements as a barrier to contraceptive access in Kenya.

Stanback J, Nutley T, Gitonga J, Qureshi Z.

East Afr Med J. 1999 Mar;76(3):124-6.

PMID:
10442109
44.
45.

Menstruation requirements: a significant barrier to contraceptive access in developing countries.

Stanback J, Thompson A, Hardee K, Janowitz B.

Stud Fam Plann. 1997 Sep;28(3):245-50. Review.

PMID:
9322340
46.

Maternal mortality in Giza, Egypt: magnitude, causes, and prevention.

Kane TT, el-Kady AA, Saleh S, Hage M, Stanback J, Potter L.

Stud Fam Plann. 1992 Jan-Feb;23(1):45-57. Erratum in: Stud Fam Plann 1992 Mar-Apr;23(2):143.

PMID:
1557794
47.

[Fewer laboratory tests before the prescription of oral contraceptives in Africa?].

Diadhiou F, Buekens P, Stanback J, De Buysscher R.

J Gynecol Obstet Biol Reprod (Paris). 1991;20(1):130. French. No abstract available.

PMID:
2019714
48.

[Apropos of the preliminary paraclinical evaluation of oral contraception].

Diadhiou F, Sangare M, Stanback J, Petrick MD, Gentile B.

Dakar Med. 1991;36(1):10-4. French.

PMID:
1842753
49.

Scanning electron microscopy of submandibular sialoliths: a preliminary report.

Brady JM, McKinney L, Stanback JS.

Dentomaxillofac Radiol. 1989 Feb;18(1):42-4.

PMID:
2599240
50.

The use of bucrylate to achieve hemostasis in tooth extraction sites.

Howard D, Whitehurst VE, Bingham R, Stanback J.

Oral Surg Oral Med Oral Pathol. 1973 Jun;35(6):762-5. No abstract available.

PMID:
4541161

Supplemental Content

Loading ...
Support Center